Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.46 USD | +1.08% | +4.06% | -15.90% |
26/04 | Cytokinetics Appoints Sung Lee as CFO | MT |
18/04 | Vir Biotechnology, Inc. Announces Stepping Down of Sung Lee as Chief Financial Officer, Effective May 3, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.90% | 1.15B | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir, GlaxoSmithKline Say Investigational COVID-19 Drug Sotrovimab Shows Activity Against Omicron Variant in Preclinical Trial